Company Filing History:
1 out of 5 
1 out of 54 
1 out of 1,745 
Years Active: 2019
Title: The Innovations of Pedro Raro in Breast Cancer Diagnosis
Introduction
Pedro Raro is an accomplished inventor based in Arville, France. He has made significant contributions to the field of breast cancer management through his innovative research and patents. His work focuses on the identification of specific biomarkers that can aid in the diagnosis of breast cancer.
Latest Patents
Pedro Raro holds a patent for his invention titled "Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer." This invention is particularly important as it relates to the diagnosis of breast cancer. The findings indicate that these specific biomarkers are abnormally expressed in the blood of breast cancer patients, providing a potential avenue for improved diagnostic methods.
Career Highlights
Throughout his career, Pedro Raro has worked with notable institutions such as the Institut de Cancérologie de l'Ouest and the Université d'Angers. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Pedro has collaborated with esteemed colleagues, including Catherine Guette and Olivier Coqueret. These partnerships have further enhanced his research and the impact of his inventions in the medical community.
Conclusion
Pedro Raro's innovative work in identifying biomarkers for breast cancer diagnosis represents a significant advancement in the field. His contributions have the potential to improve early detection and treatment options for patients, showcasing the importance of research and innovation in healthcare.